Tonghua Dongbao Pharmaceutical (600867.SH) plans to repurchase company shares worth 20 million to 40 million yuan.
Tonghua Dongbao (600867.SH) announced that the company has decided to use its own funds to repurchase company shares for employee stock ownership.
Tonghua Dongbao Pharmaceutical (600867.SH) announced that the company has decided to use its own funds to repurchase company shares for the employee stock ownership plan and/or equity incentives. The amount of this repurchase shall not be less than RMB 20 million, nor exceed RMB 40 million, with a repurchase price of no more than RMB 10 per share.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
